Antibiotic Treatment for Greenish Eye Discharge with Conjunctival Redness
For adults with greenish ocular discharge and conjunctival redness suggesting bacterial conjunctivitis, use a topical fluoroquinolone such as besifloxacin 0.6% ophthalmic suspension twice daily for 3 days, or alternatively gatifloxacin 0.3% or moxifloxacin ophthalmic solution.
Clinical Context and Pathogen Considerations
Greenish discharge with conjunctival redness is highly suggestive of bacterial conjunctivitis, particularly when purulent. The color and consistency of discharge help differentiate bacterial from viral or allergic causes. While the provided guidelines 1 focus primarily on gonococcal and chlamydial conjunctivitis requiring systemic therapy, most cases of acute bacterial conjunctivitis are caused by common pathogens (Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus influenzae) that respond well to topical antibiotics.
Treatment Algorithm
First-Line Topical Therapy (Non-Gonococcal/Non-Chlamydial)
Topical fluoroquinolones are the preferred agents:
Besifloxacin 0.6% ophthalmic suspension: Twice daily for 3 days 2
Alternative fluoroquinolones:
When to Consider Systemic Antibiotics
You must rule out gonococcal or chlamydial conjunctivitis, which require systemic therapy and present specific risks:
Gonococcal Conjunctivitis (Hyperacute Presentation)
- Clinical clues: Copious purulent discharge, severe chemosis, rapid onset, sexually active patient
- Treatment: Ceftriaxone 1g IM single dose PLUS azithromycin 1g PO single dose (to cover co-infection with Chlamydia) 1
- Critical: This can cause corneal perforation if untreated—requires urgent treatment
Chlamydial Conjunctivitis (Chronic/Follicular Pattern)
- Clinical clues: Chronic course, follicular conjunctivitis, sexually active patient, may have concurrent genital symptoms
- Treatment options 1:
- Azithromycin 1g PO single dose (preferred)
- Doxycycline 100mg PO twice daily for 7 days
- Levofloxacin 500mg PO once daily for 7 days
Special Populations
Pregnant Patients
If chlamydial infection suspected: Azithromycin 1g PO single dose OR amoxicillin 500mg PO three times daily for 7 days 1
- Avoid: Doxycycline, quinolones, tetracyclines
Children
- Topical therapy: Besifloxacin has demonstrated safety and efficacy in children ≥1 year 6, 2
- If gonococcal/chlamydial suspected: Weight-based systemic dosing per guidelines 1
Neonates
- Requires systemic therapy with ceftriaxone 25-50 mg/kg IV/IM for gonococcal infection 1
- Consider ophthalmia neonatorum—requires immediate treatment
Evidence Quality and Practical Considerations
The research evidence for topical fluoroquinolones is robust, with besifloxacin showing 86.8% bacterial eradication rates in culture-confirmed cases 2. The twice-daily dosing for 3 days offers improved compliance compared to older regimens requiring 4-6 times daily dosing 2. Gatifloxacin and moxifloxacin have comparable efficacy 3, 4.
Common pitfall: Failing to recognize hyperacute bacterial conjunctivitis (gonococcal) that requires immediate systemic antibiotics—topical therapy alone is insufficient and risks corneal complications.
Key clinical decision point: If the patient is sexually active, has a hyperacute presentation with copious discharge, or has chronic follicular conjunctivitis, obtain cultures and consider systemic therapy for gonococcal/chlamydial infection while initiating topical treatment.
Safety Profile
Topical fluoroquinolones demonstrate excellent tolerability with minimal adverse effects. In clinical trials, ocular adverse events occurred in only 4.3% of besifloxacin-treated patients versus 8.2% with vehicle, with most events being mild conjunctivitis or transient burning 2. No treatment-related systemic adverse events were reported 6, 2.